| Metalloproteinase inhibitors: biological actions and therapeutic opportunities AH Baker, DR Edwards, G Murphy Journal of cell science 115 (19), 3719-3727, 2002 | 1767 | 2002 |
| The ADAM metalloproteinases DR Edwards, MM Handsley, CJ Pennington Molecular aspects of medicine 29 (5), 258-289, 2008 | 1670 | 2008 |
| Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. DR Edwards, G Murphy, JJ Reynolds, SE Whitham, AJ Docherty, P Angel, ... The EMBO journal 6 (7), 1899-1904, 1987 | 1584 | 1987 |
| Metalloproteinases in biology and pathology of the nervous system VW Yong, C Power, P Forsyth, DR Edwards Nature Reviews Neuroscience 2 (7), 502-511, 2001 | 1294 | 2001 |
| The ADAMTS metalloproteinases S Porter, IM Clark, L Kevorkian, DR Edwards Biochemical Journal 386 (1), 15-27, 2005 | 1048 | 2005 |
| Matrix metalloproteinases and diseases of the CNS VW Yong, PA Forsyth, R Bell, CA Krekoski, DR Edwards Trends in neurosciences 21 (2), 75-80, 1998 | 828 | 1998 |
| The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family R Kelwick, I Desanlis, GN Wheeler, DR Edwards Genome biology 16 (1), 113, 2015 | 796 | 2015 |
| The regulation of matrix metalloproteinases and their inhibitors IM Clark, TE Swingler, CL Sampieri, DR Edwards The international journal of biochemistry & cell biology 40 (6-7), 1362-1378, 2008 | 763 | 2008 |
| Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. KJ Leco, R Khokha, N Pavloff, SP Hawkes, DR Edwards Journal of Biological Chemistry 269 (12), 9352-9360, 1994 | 636 | 1994 |
| Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization S Nomura, AJ Wills, DR Edwards, JK Heath, BL Hogan The Journal of cell biology 106 (2), 441-450, 1988 | 631 | 1988 |
| Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas PA Forsyth, H Wong, TD Laing, NB Rewcastle, DG Morris, H Muzik, ... British journal of cancer 79 (11), 1828-1835, 1999 | 571 | 1999 |
| Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15 (5), R92, 2013 | 564 | 2013 |
| Expression profiling of metalloproteinases and their inhibitors in cartilage L Kevorkian, DA Young, C Darrah, ST Donell, L Shepstone, S Porter, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 539 | 2004 |
| MicroRNAs and the hallmarks of cancer T Dalmay, DR Edwards Oncogene 25 (46), 6170-6175, 2006 | 511 | 2006 |
| The role of chondrocyte senescence in osteoarthritis JS Price, JG Waters, C Darrah, C Pennington, DR Edwards, ST Donell, ... Aging cell 1 (1), 57-65, 2002 | 498 | 2002 |
| Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis A Bar‐Or, RK Nuttall, M Duddy, A Alter, HJ Kim, I Ifergan, CJ Pennington, ... Brain 126 (12), 2738-2749, 2003 | 487 | 2003 |
| Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates T Stuchinskaya, M Moreno, MJ Cook, DR Edwards, DA Russell Photochemical & photobiological sciences 10 (5), 822-831, 2011 | 464 | 2011 |
| Metalloproteinases and their inhibitors in tumor angiogenesis MM Handsley, DR Edwards International journal of cancer 115 (6), 849-860, 2005 | 408 | 2005 |
| Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia AW Clark, CA Krekoski, SS Bou, KR Chapman, DR Edwards Neuroscience letters 238 (1-2), 53-56, 1997 | 400 | 1997 |
| Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions DT Denhardt, BO Feng, DR Edwards, ET Cocuzzi, UM Malyankar Pharmacology & therapeutics 59 (3), 329-341, 1993 | 372 | 1993 |
